The DOI matches its Crossref record; 229 of the 229 references it cites were found in a registry or an index.
Evaluating Causality of Gut Microbiota in Obesity and Diabetes in Humans
Open accessAbstract
The pathophysiology of obesity and obesity-related diseases such as type 2 diabetes mellitus (T2DM) is complex and driven by many factors. One of the most recently identified factors in development of these metabolic pathologies is the gut microbiota. The introduction of affordable, high-throughput sequencing technologies has substantially expanded our understanding of the role of the gut microbiome in modulation of host metabolism and (cardio)metabolic disease development. Nevertheless, evidence for a role of the gut microbiome as a causal, driving factor in disease development mainly originates from studies in mouse models: data showing causality in humans are scarce. In this review, we will discuss the quality of evidence supporting a causal role for the gut microbiome in the development of obesity and diabetes, in particular T2DM, in humans. Considering overlap in potential mechanisms, the role of the gut microbiome in type 1 diabetes mellitus will also be addressed. We will elaborate on factors that drive microbiome composition in humans and discuss how alterations in microbial composition or microbial metabolite production contribute to disease development. Challenging aspects in determining causality in humans will be postulated together with strategies that might hold potential to overcome these challenges. Furthermore, we will discuss means to modify gut microbiome composition in humans to help establish causality and discuss systems biology approaches that might hold the key to unravelling the role of the gut microbiome in obesity and T2DM.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–229 of 229
Pan, L., Qin, M., Liu, X., & Zhu, Y. Z. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00686 · Cited by 124
Maffeis, C., Martina, A., Corradi, M., Quarella, S., Nori, N., Torriani, S., Plebani, M., Contreas, G., & Felis, G. E. (2016) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2790 · Cited by 123
Yamaguchi, Y., Adachi, K., Sugiyama, T., Shimozato, A., Ebi, M., Ogasawara, N., Funaki, Y., Goto, C., Sasaki, M., & Kasugai, K. (2016) · Digestion · doi:10.1159/000447690 · Cited by 121
Delmée, E., Cani, P. D., Gual, G., Knauf, C., Burcelin, R., Maton, N., & Delzenne, N. M. (2006) · Life Sciences · doi:10.1016/j.lfs.2006.05.013 · Cited by 115
Gut microbiota composition associated with stool consistency
Tigchelaar, E. F., Bonder, M. J., Jankipersadsing, S. A., Fu, J., Wijmenga, C., & Zhernakova, A. (2015) · Gut · doi:10.1136/gutjnl-2015-310328 · Cited by 114
Roux-en-Y Gastric Bypass Corrects Hyperinsulinemia Implications for the Remission of Type 2 Diabetes
Reed, M. A., Pories, W. J., Chapman, W. H. H., Pender, J. R., Bowden, R., Barakat, H. A., Gavin, T. P., Green, T., Tapscott, E., Zheng, D., et al. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0165 · Cited by 114
Wang, X., Wang, F., You, S., Cao, Y., Cao, L.-D., Han, Q., Liu, C., & Hu, L. (2013) · Cellular Signalling · doi:10.1016/j.cellsig.2013.07.010 · Cited by 109
Doerner, K. C., Takamine, F., Lavoie, C. P., Mallonee, D. H., & Hylemon, P. B. (1997) · Applied and Environmental Microbiology · doi:10.1128/aem.63.3.1185-1188.1997 · Cited by 107
Association of Type 1 Diabetes With Month of Birth Among U.S. Youth
Kahn, H. S., Morgan, T. M., Case, L. D., Dabelea, D., Mayer-Davis, E. J., Lawrence, J. M., Marcovina, S. M., Imperatore, G., & for the SEARCH for Diabetes in Youth Study Group (2009) · Diabetes Care · doi:10.2337/dc09-0891 · Cited by 105
Prinz, P., Hofmann, T., Ahnis, A., Elbelt, U., Goebel‐Stengel, M., Klapp, B. F., Rose, M., & Stengel, A. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00199 · Cited by 100
Aron‐Wisnewsky, J., & Clément, K. (2014) · Current Atherosclerosis Reports · doi:10.1007/s11883-014-0454-9 · Cited by 89
Higher circulating bile acid concentrations in obese patients with type 2 diabetes
Vincent, R. P., Omar, S., Ghozlan, S., Taylor, D. R., Cross, G. F., Sherwood, R. A., Fändriks, L., Olbers, T., Werling, M., Alaghband‐Zadeh, J., et al. (2013) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/0004563212473450 · Cited by 88
He, X., Ji, G., Jia, W. P., & Li, H. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17030300 · Cited by 88
Targeting inflammation in the treatment of type 2 diabetes
Donath, M. Y. (2013) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12172 · Cited by 83
Gut Inflammation and Immunity: What Is the Role of the Human Gut Virome?
Focà, A., Liberto, M. C., Quirino, A., Marascio, N., Zicca, E., & Pavia, G. (2015) · Mediators of Inflammation · doi:10.1155/2015/326032 · Cited by 82
Colonic metaproteomic signatures of active bacteria and the host in obesity
Kolmeder, C. A., Ritari, J., Verdam, F. J., Muth, T., Keskitalo, S., Varjosalo, M. T., Fuentes, S., Greve, J. W. M., Buurman, W. A., Reichl, U., et al. (2015) · PROTEOMICS · doi:10.1002/pmic.201500049 · Cited by 78
Fecal microbiota transplantation for inflammatory bowel disease
Wen, H.-Z. (2016) · World Chinese Journal of Digestology · doi:10.11569/wcjd.v24.i10.1545 · Cited by 67
Rifaximin pharmacology and clinical implications
Ojetti, V., Lauritano, E. C., Barbaro, F., Migneco, A., Ainora, M. E., Fontana, L., Gabrielli, M., & Gasbarrini, A. (2009) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425250902973695 · Cited by 66
Gorus, F., Balti, E. V., Messaaoui, A., Demeester, S., Dalem, A. V., Costa, O. R., Dorchy, H., Mathieu, C., Gaal, L. V., Keymeulen, B., et al. (2017) · Diabetes Care · doi:10.2337/dc16-2228 · Cited by 66
Miao, L., Xin, X., Xin, H., Shen, X., & Zhu, Y. Z. (2016) · Scientific Reports · doi:10.1038/srep22363 · Cited by 60
Exploring the Homeostatic and Sensory Roles of the Immune System
Marques, R. E., Marques, P. E., Guabiraba, R., & Teixeira, M. M. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00125 · Cited by 52
Schwartz, R. F., Neu, J., Schatz, D., Atkinson, M. A., & Wasserfall, C. H. (2006) · Diabetologia · doi:10.1007/s00125-006-0526-7 · Cited by 50
Prevention of type 2 diabetes mellitus: is it feasible?
Palermo, A., Maggi, D., Maurizi, A. R., Pozzilli, P., & Buzzetti, R. (2013) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2513 · Cited by 49
Emerging role of hydrogen sulfide-microRNA crosstalk in cardiovascular diseases
Hackfort, B. T., & Mishra, P. K. (2016) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00660.2015 · Cited by 47
Emerging role of intestinal microbiota and microbial metabolites in metabolic control
Herrema, H., IJzerman, R. G., & Nieuwdorp, M. (2016) · Diabetologia · doi:10.1007/s00125-016-4192-0 · Cited by 46
Self-citationHoyles, L., & McCartney, A. L. (2009) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2009.01741.x · Cited by 45
Glucagon-Like Peptide 1 and the Cardiovascular System
Fava, S. (2014) · Current Diabetes Reviews · doi:10.2174/1573399810666141030125830 · Cited by 31
Groen, A. K., & Nieuwdorp, M. (2016) · EMBO Molecular Medicine · doi:10.15252/emmm.201607035 · Cited by 27
Self-citationTreuting, P. M., & Dintzis, S. M. (2011) · Elsevier eBooks · doi:10.1016/b978-0-12-381361-9.00012-3 · Cited by 24
Cited by
Adipose tissue and insulin resistance in obese
Ahmed, B., Sultana, R., & Greene, M. W. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111315 · Cited by 1,047
Obesity and type 2 diabetes mellitus: connections in epidemiology, pathogenesis, and treatments
Ruze, R., Liu, T., Zou, X., Song, J., Chen, Y., Xu, R., Yin, X., & Xu, Q. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1161521 · Cited by 799
“The truth is, the increased relative abundance of SCFAproducing microbiome and increased SCFA content in obesity is veiled by the rapid absorption by the host and the gut microbiome itself, resulting in the incompetence of SCFA disposal (120).”
BackgroundHuman gut microbiota in health and disease: Unveiling the relationship
Afzaal, M., Saeed, F., Shah, Y. A., Hussain, M., Rabail, R., Socol, C. T., Hassoun, A., Pateiro, M., Lorenzo, J. M., Rusu, A. V., et al. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.999001 · Cited by 762
Gut Microbiota as a Trigger for Metabolic Inflammation in Obesity and Type 2 Diabetes
Scheithauer, T. P. M., Rampanelli, E., Nieuwdorp, M., Vallance, B. A., Verchere, C. B., van Raalte, D. H., & Herrema, H. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.571731 · Cited by 673
Self-citationHalf a century of amyloids: past, present and future
Ke, P. C., Zhou, R., Serpell, L. C., Riek, R., Knowles, T. P. J., Lashuel, H. A., Gazit, E., Hamley, I. W., Davis, T. P., Fändrich, M., et al. (2020) · Chemical Society Reviews · doi:10.1039/c9cs00199a · Cited by 568
Metadata
- Authors
- Meijnikman, A. S., Gerdes, V. E., Nieuwdorp, M., & Herrema, H.
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2017-12-22
- Volume
- 39
- Issue
- 2
- Pages
- 133-153
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W2779718584
- Cited by
- 278
- References
- 229
- FWCI
- 9.51
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.